Fresenius Medical Care is the world’s largest dialysis services provider and has recently come under scrutiny because of one of its dialysis products called GranuFlo. GranuFlo is a dialysate that helps to remove toxins and neutralize acids in the blood when a person’s kidneys are no longer able to do so. However, the U.S. Food and Drug Administration recently took action against Fresenius Medical Care by issuing a Class 1 recall of GranuFlo, the strongest recall action that the FDA can take.
The dangers of GranuFlo are related to the amount of bicarbonates that this medication produces in the blood stream when used in dialysis treatments. For many individuals, the presence of too much bicarbonates in the blood can lead to devastating side effects, predominantly affecting the heart and related body systems. Some of the most commonly reported side effects of GranuFlo use have been heart attack, low blood pressure, cardiac arrhythmia, stroke, and unfortunately, death.
Many individuals who have suffered these side effects, or who have had family members pass because of GranuFlo use, have taken legal action against Fresenius Medical Care in an effort to secure financial compensation for their unnecessary suffering, and to hold this company responsible for the damage that their negligence has caused. Plaintiffs claim that Fresenius Medical Care failed to properly label and warn individuals about the dangers associated with GranuFlo use and as such, should be held liable for the devastating consequences that have resulted.
Through a successful GranuFlo lawsuit, victims and their families may be able to receive compensation for a number of damages, including the costs of medical care, wages that were lost due to time spent away from work recovering, emotional trauma, pain and suffering, ongoing rehabilitation costs, pharmaceutical bills, and wrongful death compensation for families who had a loved one pass away.